International recommendations for an effective control of head louse infestations

Head louse infestations continue to be a concern of public health in most countries, including the most developed ones. The present recommendations are intended to inform and stress the role and impact of the different authorities, institutions, industry, and the public in the control of head lice in order to reduce the prevalence of this parasite. We encourage health authorities to pursue more effective methods to correctly identify such infestations, and evaluate existing and new pediculicides, medical devices, louse repellents, and louse- and nit-removal remedies. Pediculicides and medical devices must have verifiable claims in the instructions for use and should be tested periodically to document current levels of resistance by lice to the active ingredients and to the formulated products. Where the prevalence of lice is claimed to be epidemic, children should be periodically evaluated objectively to document the actual level of prevalence. Continuing education for health providers and the general population promises to correct misinformation regarding the biology, prevention, and management of lice. Parents should regularly inspect their children for head lice and treat as necessary. Health authorities are encouraged to eliminate policies and practices that rely upon school exclusion as a means to reduce incidence and prevalence, e.g., the ‘no-nit’ policy which lacks scientific justification, and are counterproductive to the health and welfare of childrenFil: Mumcuoglu, Kosta Y.. The Hebrew University of Jerusalem; IsraelFil: Pollack, Richard J.. Harvard University; Estados UnidosFil: Reed, David L.. University Of Florida. Florida Museum Of History; Estados UnidosFil: Barker, Stephen C.. University of Queensland; AustraliaFil: Gordon, Shirley. Florida Atlantic University; Estados UnidosFil: Toloza, Ariel Ceferino. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones Científicas y Técnicas para la Defensa. Centro de Investigación de Plagas e Insecticidas; ArgentinaFil: Picollo, Maria Ines. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones Científicas y Técnicas para la Defensa. Centro de Investigación de Plagas e Insecticidas; ArgentinaFil: Taylan Ozkan, Aysegul. Hitit University; Turquía. Near East University; ChipreFil: Chosidow, Olivier. Hôpital Henri Mondor; FranciaFil: Habedank, Birgit. German Environment Agency; AlemaniaFil: Ibarra, Joanna. Community Hygiene Concern; Reino UnidoFil: Meinking, Terri L.. Global Health Associates of Miami; Estados UnidosFil: Vander Stichele, Robert H.. Heymans Institute of Pharmacology; Bélgic

Baş biti enfestasyonlarının etkin kontrolü için uluslararası tavsiyeler

Baş biti enfestasyonları, en gelişmiş olanlar da dâhil olmak üzere çoğu ülkede halk sağlığını ilgilendiren bir sorun olmaya devam etmektedir. Makalede sunulan tavsiyeler, bu parazitin prevalansını azaltmak amacıyla baş biti kontrolünde farklı otoritelerin, kurumların, endüstrinin ve kamunun rollerini ve etkilerini vurgulamayı ve bilgilendirmeyi amaçlamaktadır. Sağlık yetkililerini, bu tür enfestasyonların doğru şekilde tespit edilmesi; mevcut ve yeni pedikülositler, tıbbi cihazlar, repellentler, bit ve yumurta giderici ürünlerin değerlendirilmesi amacıyla daha etkili yöntemler iz açıklamalara sahip olmalı ayrıca aktif bileşenlere ve formüle ürünlere karşı bitlerin direnç seviyelerinin mevcut durumunu belgelemek için periyodik olarak test edilmelidir. Bit yaygınlığının salgın düzeyine ulaştığı iddiaları ortaya atıldığında, gerçek yaygınlık düzeyinin kanıtlanması amacıyla çocuklar periyodik aralıklarla objektif olarak değerlendirilmelidir. Sağlık hizmeti sunanlar ve toplum geneli için düzenlenen sürekli eğitimlerle bitlerin biyolojisi, önlenmesi ve kontrolü konusundaki yanlış bilgilerin düzeltilmesi sağlanabilir. Ebeveynler, çocuklarını baş biti açısından düzenli olarak kontrol etmeli ve gerektiğinde tedavi etmelidir. Sağlık yetkilileri, vakaları ve yaygınlığı azaltmada bir araç olarak kullanılan ancak bilimsel gerekçesi olmadığı gibi çocukların sağlığı ve huzuruna da ters etki yapan “sirkeye geçit yok- no-nit politikası” tarzında çocukları okuldan uzaklaştırmaya dayalı politika ve uygulamaların ortadan kaldırılması için mücadele etmelidir.lemeye teşvik etmeyi umuyoruz. Pedikülositler ve tıbbi cihazlar, kullanım talimatlarında doğrulanabilirHead louse infestations continue to be a concern of public health in most countries, including the most developed ones. The present recommendations are intended to inform and stress the role and impact of the different authorities, institutions, industry, and the public in the control of head lice in order to reduce the prevalence of this parasite. We encourage health authorities to pursue more effective methods to correctly identify such infestations, and evaluate existing and new pediculicides, medical devices, louse repellents, and louse and nit-removal remedies. Pediculicides and medical devices must have verifiable claims in the instructions for use and should be tested periodically to document current levels of resistance by lice to the active ingredients and to the formulated products. Where the prevalence of lice is claimed to be epidemic, children should be periodically evaluated objectively to document the actual level of prevalence. Continuing education for health providers and the general population promises to correct misinformation regarding the biology, prevention, and management of lice. Parents should regularly inspect their children for head lice and treat as necessary. Health authorities are encouraged to eliminate policies and practices that rely upon school exclusion as a means to reduce incidence and prevalence, e.g., the ‘no-nit’ policy which lacks scientific justification, and are countFil: Mumcuoğlu, Kosta Y.. The Hebrew University; IsraelFil: Pollack, Richard J.. Harvard University. Harvard School of Public Health; Estados UnidosFil: Reed, David. University Of Florida. Florida Museum Of History. Departamento Of Biology; Estados UnidosFil: Barker, Stephen. The University of Queensland; AustraliaFil: Gordon, Shirley. Florida Atlantic University (fau);Fil: Toloza, Ariel Ceferino. Consejo Nacional de Investigaciones Científicas y Técnicas. Unidad de Investigación y Desarrollo Estratégico para la Defensa. Ministerio de Defensa. Unidad de Investigación y Desarrollo Estratégico para la Defensa; ArgentinaFil: Picollo, Maria Ines. Consejo Nacional de Investigaciones Científicas y Técnicas. Unidad de Investigación y Desarrollo Estratégico para la Defensa. Ministerio de Defensa. Unidad de Investigación y Desarrollo Estratégico para la Defensa; ArgentinaFil: Taylan Özkan, Ayşegül. Tobb University Of Economics And Technology; TurquíaFil: Chosidow, Olivier. Hopital Henri Mondor; FranciaFil: Habedank, Birgit. German Environment Agency; AlemaniaFil: Ibarra, Joanna. Community Hygiene Concern; Reino UnidoFil: Meinking, Terri L.. Global Health Association Of Miami; Estados UnidosFil: Stichele, Robert Vander. University of Ghent; Bélgic

Ivermectin

Ivermectin is a potent antiparasitic drug and the first commercially available member of a new class of drugs (macrocyclic lactones) that has been approved for human use. Ivermectin has already proven to be highly effective in the elimination of river blindness as a public health burden. Side effects have been minor, and patient acceptance is good. Promising results in off-label applications for ectoparasitic infestations are increasingly important as resistance to topical therapy becomes more prevalent Ivermectin represents an advance in the therapeutic armamentarium and should be considered in appropriate cases